| Drug Name |
Foscarnet sodium |
| Drug ID |
BADD_D00964 |
| Description |
An antiviral agent used in the treatment of cytomegalovirus retinitis. Foscarnet also shows activity against human herpes viruses and HIV. |
| Indications and Usage |
For the treatment of CMV retinitis in patients with acquired immunodeficiency syndrome (AIDS) and for treatment of acyclovir-resistant mucocutaneous HSV infections in immunocompromised patients. |
| Marketing Status |
approved |
| ATC Code |
J05AD01 |
| DrugBank ID |
DB00529
|
| KEGG ID |
D00579
|
| MeSH ID |
D017245
|
| PubChem ID |
44561
|
| TTD Drug ID |
D0OT0O
|
| NDC Product Code |
29902-0018; 76310-024; 61662-0001; 70600-020; 59651-476; 68083-389; 63323-875; 23155-771; 79290-0001; 25021-189 |
| UNII |
964YS0OOG1
|
| Synonyms |
Foscarnet | Phosphonoformic Acid | Foscarnet Trisodium Salt | Foscarnet Calcium (2:3) Salt | Foscarnet Disodium Salt | Foscarnet Magnesium (2:3) Salt | Trisodium Phosphonoformate | Phosphonoformate | Foscarnet Sodium | Foscarnet Trilithium Salt | Foscarnet Tripotassium Salt | Foscarnet Sodium Hexahydrate | Foscavir | Foscarnet Barium (2:3) Salt | Foscarnet Manganese (2+) (2:3) Salt |
